1-5 of 5
Xiaoqiong Zhu
Close
Sort by
Journal Articles

Clinical Features and Outcomes of Polycythemia Vera Patients with Different JAK2 V617F Mutational Status and Allele Burden

Lan Zhang, Keyi Jin, Min Yang, Xiaoqiong Zhu, Jian Huang
Journal: Blood
Blood (2022) 140 (Supplement 1): 12286–12287.
https://doi.org/10.1182/blood-2022-166253
Published: 2022
Journal Articles

Targeted Next-Generation Sequencing Identifies Additional Mutations Other Than BCR-ABL in Chronic Myeloid Leukemia Patients: A Chinese Monocentric Retrospective Study

Shiwei Hu, Chen DAN, Xiaoqiong Zhu, Jian Huang
Journal: Blood
Blood (2022) 140 (Supplement 1): 9633–9634.
https://doi.org/10.1182/blood-2022-158739
Published: 2022
Journal Articles

Uncommon Hpgd Mutation Identified in Familial Erythrocytosis

Xiaoqiong Zhu, Xingnong Ye, Chen DAN, Jian Huang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4627.
https://doi.org/10.1182/blood-2021-145881
Published: 2021
Journal Articles

Gender and Marital Status Influence Survival of Myelodysplastic Syndrome and Risk of Secondary Acute Myeloid Leukemia: A Population-Based Study of Patients in the Surveillance, Epidemiology, and End Results (SEER) Database

Huang Jian, MDPhD, Xingnong Ye, Chen DAN, Xiaoqiong Zhu
Journal: Blood
Blood (2017) 130 (Supplement 1): 3464.
https://doi.org/10.1182/blood.V130.Suppl_1.3464.3464
Published: 2017
Journal Articles

Effective Treatment of Low-Doses Decitabine in Myelodysplastic Syndrome / Myeloproliferative Neoplasms with JAK2/V617F

Huang Jian, MDPhD, Xingnong Ye, Chen DAN, Xiaoqiong Zhu, Junkai FU, Yan Zheng, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5279.
https://doi.org/10.1182/blood.V130.Suppl_1.5279.5279
Published: 2017